SV2A and rhabdomyolysis: One theory suggests that levetiracetam may interact with SV2A in the motor nerve terminals of slow muscle fibers, leading to increased cholinergic neurotransmission and subsequent muscle stress, ultimately contributing to rhabdomyolysis [5].